Repros Therapeutics Inc. (RPRX) Jumps 7.34% on February 17

Equities Staff |

Repros Therapeutics Inc. (RPRX) was among the biggest gainers on the Russell 2000 for Wednesday February 17 as the stock popped 7.34% to $0.92, representing a gain of $0.0628 per share. Some 76,411 shares traded hands on 248 trades, compared with an average daily volume of 743,098 shares out of a total float of 24.32 million. The stock opened at $0.86 and traded with an intraday range of $0.94 to $0.84.

After today's gains, Repros Therapeutics Inc. reached a market cap of $22.35 million. Repros Therapeutics Inc. has had a trading range between $10.05 and $0.80 over the last year, and it had a 50-day SMA of $1.13 and a 200-day SMA of $5.18.

Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.

Repros Therapeutics Inc. is based out of The Woodlands, TX and has some 27 employees. Its CEO is .

For a complete fundamental analysis analysis of Repros Therapeutics Inc., check out’s Stock Valuation Analysis report for RPRX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Enertopia Corp

Enertopia Corp is engaged in the exploration of lithium in Nevada, USA. The Company's project includes Central Nevada Lithium Brine Projects.

Private Markets


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…